BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF- B activation

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Fu, Shou Peng ^a   Li, Su Nan ^a   Wang, Jian Fa ^a,b   Li, Yang ^a   Xie, Shan Shan ^a   Xue, Wen Jing ^a   Liu, Hong Mei ^a   Huang, Bing Xu ^a   Lv, Qing Kang ^a   Lei, Lian Cheng ^a   Liu, Guo Wen ^a   Wang, Wei ^a   Liu, Ju Xiong ^a  

^a JILIN UNIVERSITY   (China)

^b HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; CYCLOOXYGENASE 2; DRUG RECEPTOR; GPR109A PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; I KAPPA B; NF-KAPPAB INHIBITOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LEVEL; CELL STIMULATION; CONCENTRATION RESPONSE; DRUG EFFECT; ENZYME PHOSPHORYLATION; INTRACELLULAR SIGNALING; MICROGLIA; NEUROPROTECTION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; INFLAMMATION; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

3-HYDROXYBUTYRIC ACID; ANIMALS; CELL LINE; I-KAPPA B PROTEINS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84899967324     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/983401     Document Type: Article

References (43)

1. Morgan S. C., Taylor D. L., Pocock J. M., Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/ Akt and delta-Notch signalling cascades. Journal of Neurochemistry 2004 90 1 89 101 2-s2.0-3042729682 10.1111/j.1471-4159.2004.02461.x (Pubitemid 38879165)
2. Liao H., Bu W.-Y., Wang T.-H., Ahmed S., Xiao Z.-C., Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function. Journal of Biological Chemistry 2005 280 9 8316 8323 2-s2.0-14844335690 10.1074/jbc.M412730200 (Pubitemid 40349734)
3. Tanaka T., Ueno M., Yamashita T., Engulfment of axon debris by microglia requires p38 MAPK activity. Journal of Biological Chemistry 2009 284 32 21626 21636 2-s2.0-69249128292 10.1074/jbc.M109.005603
4. Colton C. A., Gilbert D. L., Production of superoxide anions by a CNS macrophage, the microglia. FEBS Letters 1987 223 2 284 288 2-s2.0-0023642584
5. Bi W., Zhu L., Wang C., Liang Y., Liu J., Shi Q., Tao E., Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation. Brain Research 2011 1395 12 20 2-s2.0-79957898338 10.1016/j.brainres.2011.04.019
6. Tai Y. F., Pavese N., Gerhard A., Tabrizi S. J., Barker R. A., Brooks D. J., Piccini P., Imaging microglial activation in Huntington's disease. Brain Research Bulletin 2007 72 2-3 148 151 2-s2.0-33847788629 10.1016/j.brainresbull. 2006.10.029 (Pubitemid 46389550)
7. Weiner H. L., The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease? Annals of Neurology 2009 65 3 239 248 2-s2.0-65249142200 10.1002/ana.21640
8. Amor S., Puentes F., Baker D., van der Valk P., Inflammation in neurodegenerative diseases. Immunology 2010 129 2 154 169 2-s2.0-73949090103 10.1111/j.1365-2567.2009.03225.x
9. Nam K. N., Koketsu M., Lee E. H., 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF- B inhibition. European Journal of Pharmacology 2008 589 1-3 53 57 2-s2.0-47549083461 10.1016/j.ejphar.2008.03.034
10. Wang M.-J., Huang H.-Y., Chen W.-F., Chang H.-F., Kuo J.-S., Glycogen synthase kinase-3 β inactivation inhibits tumor necrosis factor- α production in microglia by modulating nuclear factor B and MLK3/JNK signaling cascades. Journal of Neuroinflammation 2010 7, article 99 2-s2.0-78650654039 10.1186/1742-2094-7-99
11. Dai J.-N., Zong Y., Zhong L.-M., Li Y.-M., Zhang W., Bian L.-G., Ai Q.-L., Liu Y.-D., Sun J., Lu D., Gastrodin inhibits expression of inducible no synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-Stimulated microglia via MAPK pathways. PLoS ONE 2011 6 7 2-s2.0-79960170945 10.1371/journal.pone.0021891 e21891
12. Martindale J. L., Holbrook N. J., Cellular response to oxidative stress: Signaling for suicide and survival. Journal of Cellular Physiology 2002 192 1 1 15 2-s2.0-0036260697 10.1002/jcp.10119 (Pubitemid 34587382)
13. Ajmone-Cat M. A., de Simone R., Nicolini A., Minghetti L., Effects of phosphatidylserine on p38 mitogen activated protein kinase, cyclic AMP responding element binding protein and nuclear factor- B activation in resting and activated microglial cells. Journal of Neurochemistry 2003 84 2 413 416 2-s2.0-0037266126 10.1046/j.1471-4159.2003.01562.x (Pubitemid 36182283)
14. Hawkins R. A., Williamson D. H., Krebs H. A., Ketone-body utilization by adult and suckling rat brain in vivo. Biochemical Journal 1971 122 1 13 18 2-s2.0-0015020675
15. Laeger T., Metges C. C., Kuhla B., Role of β -hydroxybutyric acid in the central regulation of energy balance. Appetite 2010 54 3 450 455 2-s2.0-77953611169 10.1016/j.appet.2010.04.005
16. Offermanns S., The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends in Pharmacological Sciences 2006 27 7 384 390 2-s2.0-33745501028 10.1016/j.tips.2006.05.008 (Pubitemid 43963187)
17. Taggart A. K. P., Kero J., Gan X., Cai T.-Q., Cheng K., Ippolito M., Ren N., Kaplan R., Wu K., Wu T.-J., Jin L., Liaw C., Chen R., Richman J., Connolly D., Offermanns S., Wright S. D., Waters M. G., (D)- β -hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. Journal of Biological Chemistry 2005 280 29 26649 26652 2-s2.0-22844439234 10.1074/jbc.C500213200 (Pubitemid 41040696)
18. Zandi-Nejad K., Takakura A., Jurewicz M., The role of HCA2 (GPR109A) in regulating macrophage function. The FASEB Journal 2013 27 11 4366 4374 10.1096/fj.12-223933
19. Digby J. E., Martinez F., Jefferson A., Ruparelia N., Chai J., Wamil M., Greaves D. R., Choudhury R. P., Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 3 669 676 2-s2.0-84857648400 10.1161/ATVBAHA.111.241836
20. Mangmool S., Kurose H., Gi/o protein-dependent and -independent actions of pertussis toxin (ptx). Toxins 2011 3 7 884 899 2-s2.0-79960756461 10.3390/toxins3070884
21. Brückener K. E., el Bayâ A., Galla H.-J., Schmidt M. A., Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP. Journal of Cell Science 2003 116 9 1837 1846 2-s2.0-17544401216 10.1242/jcs.00378 (Pubitemid 36582170)
22. Thangaraju M., Cresci G. A., Liu K., Ananth S., Gnanaprakasam J. P., Browning D. D., Mellinger J. D., Smith S. B., Digby G. J., Lambert N. A., Prasad P. D., Ganapathy V., GPFM 09A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Research 2009 69 7 2826 2832 2-s2.0-66149084058 10.1158/0008-5472.CAN-08- 4466
23. Plaisance E. P., Lukasova M., Offermanns S., Zhang Y., Cao G., Judd R. L., Niacin stimulates adiponectin secretion through the GPR109A receptor. The American Journal of Physiology-Endocrinology and Metabolism 2009 296 3 E549 E558 2-s2.0-64749109569 10.1152/ajpendo.91004.2008
24. Mattson M. P., Camandola S., NF- B in neuronal plasticity and neurodegenerative disorders. Journal of Clinical Investigation 2001 107 3 247 254 2-s2.0-0034746288
25. Block M. L., Hong J.-S., Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Progress in Neurobiology 2005 76 2 77 98 2-s2.0-24144453087 10.1016/j.pneurobio.2005.06.004 (Pubitemid 41242883)
26. Block M. L., Zecca L., Hong J.-S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience 2007 8 1 57 69 2-s2.0-33845768784 10.1038/nrn2038 (Pubitemid 46011999)
27. Kujubu D. A., Fletcher B. S., Varnum B. C., Lim R. W., Herschman H. R., TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. Journal of Biological Chemistry 1991 266 20 12866 12872 2-s2.0-0025871150
28. Needleman P., Isakson P. C., The discovery and function of COX-2. Journal of Rheumatology 1997 24 49 6 8 2-s2.0-0030829359
29. Vijitruth R., Liu M., Choi D.-Y., Nguyen X. V., Hunter R. L., Bing G., Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. Journal of Neuroinflammation 2006 3, article 6 2-s2.0-33645867671 10.1186/1742-2094-3-6
30. Ridnour L. A., Dhanapal S., Hoos M., Nitric oxide-mediated regulation of β -amyloid clearance via alterations of MMP-9/TIMP-1. Journal of Neurochemistry 2012 123 736 749
31. Stone D. K., Kiyota T., Mosley R. L., Gendelman H. E., A model of nitric oxide induced α -synuclein misfolding in Parkinson's disease. Neuroscience Letters 2012 523 2 167 173 10.1016/j.neulet.2012.06.070
32. Liu B., Hong J.-S., Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. Journal of Pharmacology and Experimental Therapeutics 2003 304 1 1 7 2-s2.0-0037215645 10.1124/jpet.102.035048 (Pubitemid 36008905)
33. Nam K. N., Park Y.-M., Jung H.-J., Lee J. Y., Min B. D., Park S.-U., Jung W.-S., Cho K.-H., Park J.-H., Kang I., Hong J.-W., Lee E. H., Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. European Journal of Pharmacology 2010 648 1-3 110 116 2-s2.0-77957755920 10.1016/j.ejphar.2010. 09.003
34. Perkins N. D., Integrating cell-signalling pathways with NF- B and IKK function. Nature Reviews Molecular Cell Biology 2007 8 1 49 62 2-s2.0-33845768987 10.1038/nrm2083 (Pubitemid 46012014)
35. Hayden M. S., Ghosh S., Shared Principles in NF- B Signaling. Cell 2008 132 3 344 362 2-s2.0-38849199203 10.1016/j.cell.2008.01.020 (Pubitemid 351192002)
36. Ghosh S., Hayden M. S., New regulators of NF- B in inflammation. Nature Reviews Immunology 2008 8 11 837 848 2-s2.0-54949147176 10.1038/nri2423
37. Kawashita E., Tsuji D., Toyoshima M., Kanno Y., Matsuno H., Itoh K., Prostaglandin E2 reverses aberrant production of an inflammatory chemokine by microglia from sandhoff disease model mice through the cAMP-PKA pathway. PLoS ONE 2011 6 1 e16269 2-s2.0-79551511690 10.1371/journal.pone.0016269 e16269
38. Morioka N., Tanabe H., Inoue A., Dohi T., Nakata Y., Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via β -adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia. Neurochemistry International 2009 55 4 226 234 2-s2.0-67349143648 10.1016/j.neuint.2009.03.004
39. Pyo H., Jou I., Jung S., Joe E., cAMP potentiates β -amyloid-induced nitric oxide release from microglia. NeuroReport 1999 10 1 37 40 2-s2.0-0033580101 (Pubitemid 29090474)
40. Makranz C., Cohen G., Reichert F., Kodama T., Rotshenker S., cAMP cascade (PKA, Epac, adenylyl cyclase, Gi, and phosphodiesterases) regulates myelin phagocytosis mediated by complement receptor-3 and scavenger receptor-AI/II in microglia and macrophages. GLIA 2006 53 4 441 448 2-s2.0-33644512079 10.1002/glia.20303
41. Tynan R. J., Weidenhofer J., Hinwood M., Cairns M. J., Day T. A., Walker F. R., A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain, Behavior, and Immunity 2012 26 3 469 479 2-s2.0-84857192442 10.1016/j.bbi.2011.12.011
42. Agarwal N., Lamichhane G., Gupta R., Nolan S., Bishai W. R., Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase. Nature 2009 460 7251 98 102 2-s2.0-67650074482 10.1038/nature08123
43. Yuan L., Wu Y., Ren X., Isoorientin attenuates lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-related MAPK/NF- B signaling pathway in BV-2 microglia. Molecular and Cellular Biochemistry 2013 1 13